To identify DEGs that are common across different disease-types driven by ASXL1 variants, we integrated these AML-ASXL1 DEGs (AML-ASXL1 compared to tissue-matched controls) with the 2118 significant DEGs previously identified in BOS blood samples (BOS n = 8 compared to healthy controls n = 11) [28]. The gene discussed is ASXL1; the disease is acute myeloid leukemia.